MESO FY 2008 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$909,807-45.8% YoY

Gross Profit

$909,807100.0% margin

Operating Income

-$8M-872.7% margin

Net Income

-$10M-1106.0% margin

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$28M

Total Liabilities

$2M

Stockholders' Equity

$26M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$909,807	$2M	-45.8%
Gross Profit	$909,807	$2M	-45.8%
Operating Income	-$8M	-$7M	-13.2%
Net Income	-$10M	-$9M	-15.3%